3 unknown, 2 completed, 1 terminated. 2 Phase 3, 1 Not applicable, 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Unknown 1 |
| Not applicable | 1 | Unknown 1 |
| Phase 2 | 1 | Completed 1 |
| Phase 4 | 1 | Terminated 1 |
Follow Sinusitis, Acute: new trials by email Literature Review of Sinusitis, Acute trials Research Report on Sinusitis, Acute
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| "Association of Peri-implantitis and Maxillary Sinusitis: a Case-control Study". Retrospective analysis of demographic and radiographic data previously obtained from the patient. - Peri-Implantitis, Sinusitis | Unknown | Universitat Internacional de Catalunya | 40 | 2023-06-06 | 2023-06-29 | |
| Endoscopic Sinus Surgery in Recurrent Acute Rhinosinusitis Endoscopic sinus surgery (ESS) - Maxillary Sinusitis, Sinusitis, Acute | Not applicable | Unknown | Oulu University Hospital | 80 | 2020-05-01 | 2023-05-31 |
| Efficacy and Safety of Modified Release Cefpodoxime Formulation in the Treatment of Acute Sinusitis. Infex 400 MR, Infex 200 IR - Sinusitis, Sinusitis, Acute | Phase 3 | Unknown | Neutec Ar-Ge San ve Tic A.Ş | 100 | 2019-05-15 | 2023-01-05 |
| Treatment of Acute Sinusitis With High-Dose vs. Standard-Dose Amoxicillin/Clavulanate Amoxicillin 875 mg, Placebo (lactase) - Sinusitis, Acute | Phase 4 | Terminated | Paul Sorum, MD | 157 | 2018-02-26 | 2021-08-12 |
| Study to Assess the Efficacy and Safety of Potassium Clavulanate/Amoxicillin in Children With Acute Bacterial Rhinosinusitis Amoxicillin-Potassium Clavulanate Combination - Sinusitis, Acute | Phase 3 | Completed | GlaxoSmithKline | 27 | 2013-08-30 | 2017-07-11 |
| Dose Finding Study of Fluticasone Furoate Nasal Spray for Uncomplicated Acute Rhinosinusitis FFNS 110 mcg QD, FFNS 110 mcg BID, Placebo Nasal Spray - Sinusitis, Acute | Phase 2 | Completed | GlaxoSmithKline | 741 | 2010-01-06 | 2017-05-17 |
Sinusitis (6) · Bronchiolitis Obliterans Syndrome (1) · Infections (1) · Maxillary Sinusitis (1) · Peri-Implantitis (1) · Rhinosinusitis (1)
Nose Diseases (6) · Otorhinolaryngologic Diseases (6) · Paranasal Sinus Diseases (6) · Respiratory Tract Diseases (6) · Respiratory Tract Infections (6) · Infections (5) · Bronchial Diseases (1) · Bronchiolitis (1) · Bronchiolitis Obliterans (1) · Bronchitis (1) · Graft vs Host Disease (1) · Immune System Diseases (1) · Lung Diseases (1) · Lung Diseases, Obstructive (1) · Mouth Diseases (1)
Amoxicillin (1) · Amoxicillin-Potassium Clavulanate Combination (1) · BID protein, human (1) · Lactase (1)
GlaxoSmithKline (2) · Neutec Ar-Ge San ve Tic A.Ş (1) · Oulu University Hospital (1) · Paul Sorum, MD (1) · Universitat Internacional de Catalunya (1)
Spain (2) · Bulgaria (1) · Canada (1) · Czechia (1) · Estonia (1) · Finland (1) · Germany (1) · Japan (1) · Netherlands (1) · Norway (1) · Poland (1) · Russia (1) · Sweden (1) · Turkey (Türkiye) (1) · Ukraine (1)
Jose Nart, PhD (1) · Olli-Pekka Alho, MD, PhD (1) · Paul C Sorum, MD, PhD (1)